TipRanks
Lakefront Biotherapeutics (DE:GXEA)
FRANKFURT:GXEA
Germany Market

Lakefront Biotherapeutics (GXEA) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Lakefront Biotherapeutics’s (GXEA) Moving Averages Convergence Divergence (MACD) indicator is 0.77, suggesting Lakefront Biotherapeutics is a Sell.
Lakefront Biotherapeutics’s (GXEA) 20-Day exponential moving average is 27.02, while Lakefront Biotherapeutics’s (GXEA) share price is €25.4, making it a Buy.
Lakefront Biotherapeutics’s (GXEA) 50-Day exponential moving average is 26.05, while Lakefront Biotherapeutics’s (GXEA) share price is €25.4, making it a Buy.

Lakefront Biotherapeutics (GXEA) Pivot Points

Nov 01, 2026, 12:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
28.40
28.40
28.40
28.40
28.40
28.40
28.40
Fibonacci
28.40
28.40
28.40
28.40
28.40
28.40
28.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lakefront Biotherapeutics (GXEA) Moving Averages

Nov 01, 2026, 12:49 AM
Period
Simple
Exponential
MA5
28.28Buy
28.19Buy
MA10
27.48Buy
27.67Buy
MA20
26.79Buy
27.02Buy
MA50
25.64Buy
26.05Buy
MA100
25.28Buy
25.60Buy
MA200
25.72Buy
25.99Buy
Lakefront Biotherapeutics’s (GXEA) 10-Day exponential moving average is 27.67, while Lakefront Biotherapeutics’s (GXEA) share price is €25.4, making it a Buy.
Lakefront Biotherapeutics’s (GXEA) 100-Day exponential moving average is 25.60, while Lakefront Biotherapeutics’s (GXEA) share price is €25.4, making it a Buy.
Lakefront Biotherapeutics’s (GXEA) stock price is €25.4 and Lakefront Biotherapeutics’s (GXEA) 50-day simple moving average is 25.64, creating a Buy signal.
Lakefront Biotherapeutics’s (GXEA) stock price is €25.4 and Lakefront Biotherapeutics’s (GXEA) 100-day simple moving average is 25.28, creating a Buy signal.
Lakefront Biotherapeutics’s (GXEA) stock price is €25.4 and Lakefront Biotherapeutics’s (GXEA) 200-day simple moving average is 25.72, creating a Buy signal.

Lakefront Biotherapeutics (GXEA) Technical Indicators

Nov 01, 2026, 12:49 AM
Name
Value
Implied Action
RSI (14)
70.56
Sell
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
0.77
Sell
ADX (14)
23.51
Neutral
CCI (14)
153.32
Sell
ATR (14)
0.36
-
Ultimate Oscillator
80.48
Buy
ROC
9.16
Buy
Bull/Bear Power (13)
2.32
Buy
Lakefront Biotherapeutics’s (GXEA) Relative Strength Index (RSI) is 70.56, creating a Sell signal.
Lakefront Biotherapeutics’s (GXEA) Trend Strength Indicator (ADX) is 23.51, creating a Neutral signal.
Lakefront Biotherapeutics’s (GXEA) Commodity Channel Index (CCI) is 153.32, creating a Sell signal.
Lakefront Biotherapeutics’s (GXEA) Price Rate of Change (ROC) is 9.16, creating a Buy signal.

FAQ

Is GXEA a Buy, Hold, or Sell?
Based on GXEA’s technical indicators, GXEA is a Buy.
    What is GXEA’s RSI (14)?
    GXEA’s RSI (14) is 70.56, which suggests GXEA is a Sell.
      What is GXEA’s MACD?
      GXEA’s MACD is 0.77, which suggests GXEA is a Sell.
        What is GXEA’s 5-day moving average?
        GXEA’s 5-day moving average is 28.28, which suggests GXEA is a Buy.
          What is GXEA’s 20-day moving average?
          GXEA 20-day moving average is 26.79, which suggests GXEA is a Buy.
            What is GXEA’s 50-day moving average?
            GXEA’s 50-day moving average is 25.64, which suggests GXEA is a Buy.
              What is GXEA’s 200-day moving average?
              GXEA’s 200-day moving average is 25.72, which suggests GXEA is a Buy.
                What is GXEA’s Williams % R (14)?
                Currently, no data Available
                What is GXEA’s CCI (14)?
                GXEA’s CCI (14) is 153.32, which suggests GXEA is a Sell.
                  What is the share price of Lakefront Biotherapeutics?